Education
About Us
Working with TipRanks
Follow Us
Zivo Bioscience Inc (ZIVO)
OTHER OTC:ZIVO
Total Valuation
Zivo Bioscience has a market cap or net worth of $38.46M. The enterprise value is $61.41M.
Market Cap$38.46M
Enterprise Value$61.41M
Share Statistics
Zivo Bioscience has 3,888,595 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,888,595
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zivo Bioscience’s return on equity (ROE) is 26.00 and return on invested capital (ROIC) is 5128.62%.
Return on Equity (ROE)26.00
Return on Assets (ROA)-8.15
Return on Invested Capital (ROIC)5128.62%
Return on Capital Employed (ROCE)33.51
Revenue Per Employee22.46K
Profits Per Employee-1.91M
Employee Count7
Asset Turnover0.10
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Zivo Bioscience is ―. Zivo Bioscience’s PEG ratio is 0.37.
PE Ratio―
PS Ratio466.38
PB Ratio-142.41
Price to Fair Value-142.41
Price to FCF-17.00
Price to Operating Cash Flow-12.37
PEG Ratio0.37
Income Statement
In the last 12 months, Zivo Bioscience had revenue of 157.22K and earned -13.38M in profits. Earnings per share was -3.92.
Revenue157.22K
Gross Profit48.95K
Operating Income-13.36M
Pretax Income-13.38M
Net Income-13.38M
EBITDA-13.36M
Earnings Per Share (EPS)-3.92
Cash Flow
In the last 12 months, operating cash flow was -3.08M and capital expenditures 0.00, giving a free cash flow of -3.08M billion.
Operating Cash Flow-3.08M
Free Cash Flow-3.08M
Free Cash Flow per Share-0.79
Dividends & Yields
Zivo Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.07
52-Week Price Change-55.15%
50-Day Moving Average11.52
200-Day Moving Average14.34
Relative Strength Index (RSI)47.00
Average Volume (3m)586.00
Important Dates
Zivo Bioscience upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Zivo Bioscience as a current ratio of 0.80, with Debt / Equity ratio of -13.15%
Current Ratio0.80
Quick Ratio0.80
Debt to Market Cap<0.01
Net Debt to EBITDA0.10
Interest Coverage Ratio-582.50
Taxes
In the past 12 months, Zivo Bioscience has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Zivo Bioscience EV to EBITDA ratio is -5.39, with an EV/FCF ratio of -16.70.
EV to Sales458.19
EV to EBITDA-5.39
EV to Free Cash Flow-16.70
EV to Operating Cash Flow-16.70
Balance Sheet
Zivo Bioscience has $57.22K in cash and marketable securities with $432.30K in debt, giving a net cash position of -$375.07K billion.
Cash & Marketable Securities$57.22K
Total Debt$432.30K
Net Cash-$375.07K
Net Cash Per Share-$0.10
Tangible Book Value Per Share-$0.15
Margins
Gross margin is 31.68%, with operating margin of -8498.85%, and net profit margin of -8513.44%.
Gross Margin31.68%
Operating Margin-8498.85%
Pretax Margin-8513.44%
Net Profit Margin-8513.44%
EBITDA Margin-8498.85%
EBIT Margin-8498.85%
Analyst Forecast
The average price target for Zivo Bioscience is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast164.52%
EPS Growth Forecast53.47%